易方达恒生港股通创新药ETF
(159316)公募股票型指数型
各季度资产配置
| 季报日期 | 净资总值(亿元) | 净资净值(亿元) | 股票 | 债券 | 现金 | 其他 | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | 市值(亿元) | 占净值比例(%) | 占总值比例(%) | |||
| 2026-03-31 | 42.13 | 42.06 | 41.68 | 98.93% | 98.93% | 0.00 | 0.00% | 0.00% | 0.45 | 1.07% | 1.07% | 0.00 | 0.00% | 0.00% |
| 2025-12-31 | 40.09 | 39.82 | 39.35 | 98.14% | 98.15% | 0.00 | 0.00% | 0.00% | 0.74 | 1.86% | 1.85% | 0.00 | 0.00% | 0.00% |
| 2025-09-30 | 30.01 | 28.89 | 28.52 | 94.81% | 95.01% | 0.00 | 0.00% | 0.00% | 1.47 | 5.10% | 4.90% | 0.02 | 0.09% | 0.09% |
| 2025-06-30 | 4.60 | 4.07 | 3.96 | 84.35% | 86.15% | 0.00 | 0.00% | 0.00% | 0.62 | 15.24% | 13.49% | 0.02 | 0.41% | 0.36% |